These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28917586)

  • 1. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
    Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
    Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy.
    Loap P; Tkatchenko N; Goudjil F; Ribeiro M; Baron B; Fourquet A; Kirova Y
    Acta Oncol; 2021 Aug; 60(8):1038-1044. PubMed ID: 33788665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
    Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
    Front Oncol; 2019; 9():1456. PubMed ID: 31998635
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.
    Fan LL; Luo YK; Xu JH; He L; Wang J; Du XB
    J Appl Clin Med Phys; 2014 Sep; 15(5):4624. PubMed ID: 25207559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
    Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
    Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Wang X; Tian Y; Tang Y; Hu ZH; Zhang JJ; Fu GS; Ma P; Ren H; Zhang T; Li N; Liu WY; Fang H; Li YX; Jin J
    Oncotarget; 2017 Jun; 8(24):39727-39735. PubMed ID: 28061474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tumor morphology and dosimetric parameters of organs at risk after intensity-modulated radiotherapy in esophagus cancer.
    Li F; Luo Y; Chen J; He L; Liang Y; Lai J; Guo F
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13612. PubMed ID: 35635800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
    Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
    Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer.
    Zhang Y; Jabbour SK; Zhang A; Liu B; Yue NJ; Biswal NC
    Med Dosim; 2021 Autumn; 46(3):229-235. PubMed ID: 33454170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 20. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
    Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.